Related Experiment Video
Updated: Aug 21, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
As-Needed Versus Regular Intranasal Corticosteroid Therapy in Pediatric Perennial Allergic Rhinitis: A Randomized
Supaluk Chatmaitri1, Ongon Boonnijasin1, Apiradee Wisitsartkul2
1Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Insights
Regular intranasal corticosteroid (INCS) use showed early benefits for pediatric perennial allergic rhinitis (PAR) symptom control compared to as-needed use. However, these clinical advantages diminished over time, suggesting as-needed INCS may be a viable alternative for some patients.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Pharmacology
Background:
- Intranasal corticosteroids (INCS) are the primary treatment for allergic rhinitis (AR).
- Daily adherence to INCS can be challenging for pediatric patients.
- Limited evidence exists comparing regular versus as-needed INCS for pediatric perennial allergic rhinitis (PAR).
Purpose of the Study:
- To assess the efficacy and safety of regular versus as-needed INCS in children with PAR.
- To evaluate the anti-inflammatory effects of different INCS dosing strategies.
- To compare symptom scores, quality of life, and nasal cytology between treatment groups.
Main Methods:
- An 8-week, randomized, double-blind, double-dummy trial involving 70 children (aged 6-18) with PAR.
- Participants were assigned to regular or as-needed intranasal fluticasone furoate.
- Outcomes included symptom scores, visual analog scales, quality of life, nasal cytology, and adverse events.
Main Results:
- Regular INCS showed superior early improvements in total, nasal, and ocular symptom scores and nasal airflow compared to as-needed use.
- These early clinical differences were not sustained by week 8.
- Regular INCS led to greater reductions in nasal eosinophils and basophilic cells, while as-needed use resulted in lower cumulative INCS exposure.
- Adverse events were similar, with epistaxis noted only in the as-needed group.
Conclusions:
- Regular INCS use provides initial clinical and anti-inflammatory benefits over as-needed use in pediatric PAR.
- The clinical benefits of regular INCS did not persist throughout the 8-week study period.
- As-needed INCS demonstrated symptom improvement from baseline and may be a suitable alternative for symptom management in select pediatric PAR patients.
Background:
Intranasal corticosteroids (INCS) are the most effective monotherapy for allergic rhinitis (AR), but daily adherence remains challenging. Evidence comparing regular versus as-needed INCS use in pediatric perennial allergic rhinitis (PAR) is limited.
Objective:
To evaluate the efficacy, safety, and anti-inflammatory effects of regular versus as-needed INCS in pediatric PAR.
Methods:
In this 8-week, randomized, double-blind, double-dummy trial, 70 children aged 6-18 years with PAR were assigned (1:1) to regular or as-needed intranasal fluticasone furoate. Key outcomes included total, nasal, and ocular symptom scores (TSS, TNSS, TOSS), visual analog scale (VAS), parent-assessed scores, Rhinoconjunctivitis Quality of Life-36 (RCQ-36), peak nasal inspiratory flow (PNIF), nasal cytology, INCS exposure, and adverse events.
Results:
Sixty-eight patients completed the trial (as-needed, n=33; regular, n=35). Regular treatment demonstrated greater improvements in TSS, TNSS, TOSS, VAS, PVAS, and PNIF than as-needed treatment at selected early time points (all P<0.05). However, these differences were not sustained through week 8. No significant between-group differences were observed in PTSS, PTNSS, PTOSS, or RCQ-36 scores. At week 8, regular treatment yielded greater reductions in mucosal eosinophils and basophilic metachromatic cells (P<0.05). Cumulative INCS exposure was lower with as-needed treatment (P<0.05). Adverse events were comparable, although epistaxis occurred only in the as-needed group (P=0.02).
Conclusion:
Regular INCS use was associated with greater early clinical and antiinflammatory benefits than as-needed use in pediatric PAR, without increased adverse events. However, between-group clinical differences were not sustained through week 8. As-needed treatment also improved outcomes from baseline and may be an alternative for symptom control in selected patients.
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids